Therapeutic Advances in Respiratory Disease (Apr 2024)

Optimal flow of high-flow nasal cannula oxygenation to prevent desaturation during sedation for bronchoscopy: a randomized controlled study

  • Wen Zhang,
  • Xiaohong Yuan,
  • Yajian Shen,
  • Jiangling Wang,
  • Kangjie Xie,
  • Xinzhong Chen

DOI
https://doi.org/10.1177/17534666241246637
Journal volume & issue
Vol. 18

Abstract

Read online

Background: Although high-flow nasal cannula (HFNC) oxygenation is currently recommended to prevent desaturation during sedation for bronchoscopy, there is no consensus on an optimal flow rate. Objective: To determine the optimal oxygen flow rate for HFNC to effectively prevent desaturation during sedation for bronchoscopy. Design: Prospective, randomized, and controlled study. Methods: Patients ( n = 240) scheduled for bronchoscopy were randomized to receive HFNC with propofol sedation (fraction of inspired oxygen, 100%) at one of six flow rates of 10, 20, 30, 40, 50, and 60 L/min, designated as groups 1–6, respectively. Results: The incidence of desaturation significantly decreased by increasing the oxygen flow rate (42.5%, 17.5%, 15%, 10%, 2.5%, and 0% for groups 1–6, respectively, p < 0.0001). The optimal oxygen flow rate for HFNC determined by probit regression to effectively prevent desaturation in 95% of patients was 43.20 (95% confidence interval, 36.43–55.96) L/min. The requirement for airway intervention was significantly decreased by increasing the oxygen flow rate. Conclusion: An HFNC flow rate of 50–60 L/min is recommended to prevent desaturation during sedation for bronchoscopy. Registration: NCT05298319 at ClinicalTrials.gov.